• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK VASCULAR INC VITAL-PORT ATTACHED SILICONE CATHETER WITH INT TITANIUM POWER INJECTABLE PORT LIT CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK VASCULAR INC VITAL-PORT ATTACHED SILICONE CATHETER WITH INT TITANIUM POWER INJECTABLE PORT LIT CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number N/A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Inflammation (1932)
Event Date 04/29/2016
Event Type  Injury  
Manufacturer Narrative

(b)(4). Investigation / evaluation: no product, images, nor packaging were returned to assist in the evaluation. However, a review of the complaint history, device history record and documentation was conducted during the investigation procedure. Based on the customer report, an implanted vital port had to be removed due to a patient reaction 2 days after implantation. There are no signs of long-term harm from this event. A review of records found that all process parameters were within specifications, no deviations, no anomalies were found. No signs were found of a manufacturing nonconformity, breach of packaging, or deviation to the sterilization process. All sterilization parameters were within specifications, which were validated to meet a sterility assurance level. There are no signs of a sterility failure. Per the investigation, no signs were found to indicate that the device contained a nonconformity that could lead to a patient reaction. All devices and implantable components were cleaned prior to packaging and all other manufacturing steps were performed and reviewed by trained personnel. No details of the implantation technique or process were provided; which are possible causes of infection or irritation. Without more information, the root cause of this complaint is unknown. The appropriate internal personnel have been notified and we will continue to monitor for further complaints.

 
Event Description

The (b)(6) year old male patient with pre-existing condition of cancer had a vital port implanted on (b)(6) 2016 and is being removed on (b)(6) 2016, due to what appeared to be signs of infection or a reaction. The dr said the patient was imunosupressed, thin and 3 attempts had been made in gaining access into the patients right internal jugular; which collapsed and had difficulties with the wire. Patient had redness at and above the port pocket and was warm to touch but not below. Redness was also noted at the insertion site. The incision / wound site was clean and appeared to be fine. Patient was given cephazolon antibiotics and the port is scheduled to be removed in the next 24 hours and will be sent to pathology for testing. Dr accessed to flush and heplock the port. Patient went home, is yet to receive treatment.

 
Manufacturer Narrative

Common device name: lit catheter, angioplasty, peripheral, transluminal. (b)(4). Pma/510k: k081425. Investigation - evaluation. A review of complaint history, device record history, documentation, and visual inspection of the returned device was conducted during the investigation. One used vital-port attached silicone catheter was returned along with a catheter lock and a length of catheter (~35 cm) the visual examination reported mold was observed on the device upon receipt and prior to disinfection. There are no signs that the mold was present on the device while it was removed from the patient. It appears that the device was not cleaned following explantation and was shipped from overseas, which would provide many opportunities for microbial growth. The catheter and catheter lock were observed to be properly connected to the vital port housing per the instruction for use ( ifu). The device was inspected under magnification, and no signs of damage, anomaly, or nonconformity were observed. The packaging was not returned, and no information about the packaging was provided. Review of device history record shows no nonconforming events which could contribute to this failure mode. The manufacturing record for this lot was reviewed, and nothing of note was observed. Based on the information provided and the results of our investigation, a definitive root cause could not be determined. Per the quality engineering risk assessment (qera) no further action is required.

 
Event Description

The (b)(6) male patient with pre-existing condition of cancer had a vital port implanted on (b)(6) 2016 and is being removed on (b)(6) 2016, due to what appeared to be signs of infection or a reaction. The dr said the patient was immunosuppressed, thin and 3 attempts had been made in gaining access into the patients right internal jugular; which collapsed and had difficulties with the wire. Patient had redness at and above the port pocket and was warm to touch but not below. Redness was also noted at the insertion site. The incision / wound site was clean and appeared to be fine. Patient was given cephazolon antibiotics and the port is scheduled to be removed in the next 24 hours and will be sent to pathology for testing. Dr accessed to flush and heplock the port. Patient went home, is yet to receive treatment.

 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameVITAL-PORT ATTACHED SILICONE CATHETER WITH INT TITANIUM POWER INJECTABLE PORT
Type of DeviceLIT CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
COOK VASCULAR INC
1186 montgomery lane
vandergrift PA 15690
Manufacturer Contact
rita harden
750 daniels way
bloomington, IN 47404
8128294891
MDR Report Key5672740
MDR Text Key45692216
Report Number1820334-2016-00330
Device Sequence Number1
Product Code LIT
Combination Product (Y/N)N
Reporter Country CodeAU
PMA/PMN NumberK081425
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type DISTRIBUTOR,FOREIGN
Reporter Occupation
Type of Report Initial,Followup
Report Date 04/29/2016
1 Device Was Involved in the Event
1 Patient Was Involved in the Event
Date FDA Received05/23/2016
Is This An Adverse Event Report? Yes
Is This A Product Problem Report? No
Device Operator HEALTH PROFESSIONAL
Device MODEL NumberN/A
Device Catalogue NumberIP-S9010
Was Device Available For Evaluation? Yes
Is The Reporter A Health Professional? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/29/2016
Device Age3 mo
Event Location Hospital
Date Manufacturer Received04/29/2016
Was Device Evaluated By Manufacturer? Yes
Date Device Manufactured01/19/2016
Is The Device Single Use? Yes
Is this a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient TREATMENT DATA
Date Received: 05/23/2016 Patient Sequence Number: 1
-
-